Literature DB >> 10846263

Current understanding of androgenetic alopecia. Part I: etiopathogenesis.

R Hoffmann1, R Happle.   

Abstract

Androgenetic alopecia (AGA) is the most common type of hair loss in men and women. This continuous process results in a type of alopecia that follows a definite pattern in those individuals who are genetically predisposed. At present the predisposing genes are unknown but the relatively strong concordance of the degree of baldness in fathers and sons is not consistent with a simple Mendelian trait and a polygenic basis is therefore most likely. AGA can be defined as a DHT-dependent process with continuous miniaturization of sensitive HF. Today we do not understand the molecular steps involved in androgen-dependent beard growth versus androgen-dependent hair loss in AGA. However, recent experimental and clinical advances enable us to explain some pathogenetic steps leading to androgenetic hair loss. Among other steroidogenic isoenzymes such as 17b- and 3b- hydroxysteroid dehydrogenases, the type 2 5a-reductase within the dermal papilla plays a central role by the intrafollicular conversion of T to DHT.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846263

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  13 in total

Review 1.  Therapeutic strategy for hair regeneration: hair cycle activation, niche environment modulation, wound-induced follicle neogenesis, and stem cell engineering.

Authors:  Shan-Chang Chueh; Sung-Jan Lin; Chih-Chiang Chen; Mingxing Lei; Ling Mei Wang; Randall Widelitz; Michael W Hughes; Ting-Xin Jiang; Cheng Ming Chuong
Journal:  Expert Opin Biol Ther       Date:  2013-01-05       Impact factor: 4.388

Review 2.  [Androgenetic alopecia. Current aspects of a common phenotype].

Authors:  S Hanneken; S Ritzmann; M M Nöthen; R Kruse
Journal:  Hautarzt       Date:  2003-08       Impact factor: 0.751

Review 3.  Interventions for female pattern hair loss.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Jan Schoones
Journal:  Cochrane Database Syst Rev       Date:  2016-05-26

Review 4.  Low-level laser (light) therapy (LLLT) for treatment of hair loss.

Authors:  Pinar Avci; Gaurav K Gupta; Jason Clark; Norbert Wikonkal; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2013-08-23       Impact factor: 4.025

5.  Topical melatonin for treatment of androgenetic alopecia.

Authors:  Tobias W Fischer; Ralph M Trüeb; Gabriella Hänggi; Marcello Innocenti; Peter Elsner
Journal:  Int J Trichology       Date:  2012-10

Review 6.  Rooster feathering, androgenic alopecia, and hormone-dependent tumor growth: what is in common?

Authors:  Julie Ann Mayer; Cheng-Ming Chuong; Randall Widelitz
Journal:  Differentiation       Date:  2004-12       Impact factor: 3.533

7.  Validity of self reported male balding patterns in epidemiological studies.

Authors:  Rosalind Taylor; Julia Matassa; Justine E Leavy; Lin Fritschi
Journal:  BMC Public Health       Date:  2004-12-13       Impact factor: 3.295

8.  Hormonal profile in Indian men with premature androgenetic alopecia.

Authors:  Smita Narad; Sushil Pande; Madhur Gupta; Suresh Chari
Journal:  Int J Trichology       Date:  2013-04

9.  Metabolic syndrome and skin: psoriasis and beyond.

Authors:  Tanmay Padhi
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

10.  Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study.

Authors:  Joaquin J Jimenez; Tongyu C Wikramanayake; Wilma Bergfeld; Maria Hordinsky; Janet G Hickman; Michael R Hamblin; Lawrence A Schachner
Journal:  Am J Clin Dermatol       Date:  2014-04       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.